Moving North, page-23

"Some of the best shorts are on 'me too' runs which have no underlying justification"

Cynata have their own significant catalysts expected to occur over the next 3-12 months including:

• Results from P1 Diabetic Foot Ulcer Trial
• Commercial partnership of Diabetic Foot Ulcer/Wound indication with upfront cash payment
• Commencement of P1 Renal Transplantation Therapy
• Results of P1 Renal Transplantation Therapy
• Complete recruitment in P2 Adult HR-aGvHD treatment
• Results from P2 Adult HR-aGvHD treatment

And then in 18 months, the readouts from the Phase 3 Knee Osteoarthritis trial will be available. And likely a GvHD partnership, too.